Please provide your email address to receive an email when new articles are posted on . A transcatheter mitral valve replacement system was approved for patients at high surgical risk. The system is ...

The US Food and Drug Administration has approved the Tendyne transcatheter mitral valve replacement (TMVR) system for the treatment of patients with mitral valve dysfunction, device manufacturer ...

Infective endocarditis (IE) over the long term is much more common in patients who have undergone mitral valve (MV) replacement surgery than in those treated with MV repair or who have a moderate risk ...

Mitral valve regurgitation is a heart condition that occurs when the mitral valve does not close properly, allowing blood to flow backward into the left atrium. Symptoms do not always occur. When they ...

During what has been a rollercoaster-like pattern for more than a decade, market expectations for transcatheter mitral valve replacement (TMVR) devices are continuing to follow an upward trajectory in ...